Disclosures for "30-Day Readmission Rates of Drug Resistant Epilepsy Subjects Undergoing Operative Intervention – A Single Center Study"
-
Mr. Shan has nothing to disclose.
-
Dr. Hays has nothing to disclose.
-
Dr. Alick-Lindstrom has received personal compensation in the range of $5,000-$9,999 for serving as a consultant with megin.
-
The institution of Dr. Ding has received research support from National Institute of Aging. The institution of Dr. Ding has received research support from NINDS.
-
The institution of Bradley Lega has received research support from NIH.
-
Irina Podkorytova has nothing to disclose.
-
Dr. Harvey has received personal compensation for serving as an employee of Neuralogix. Dr. Harvey has received personal compensation for serving as an employee of Integris . Dr. Harvey has received personal compensation for serving as an employee of Neurovative. Dr. Harvey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Azurity Pharmaceuritcals. Dr. Harvey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals.
-
Dr. Agostini has nothing to disclose.
-
Dr. Perven has nothing to disclose.
-
Dr. Dieppa has nothing to disclose.
-
Dr. Doyle has nothing to disclose.
-
The institution of Dr. Zepeda has received research support from NIH.
-
Dr. Das has received personal compensation for serving as an employee of Concentra.